A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
for Advanced or Metastatic Solid Tumors
14 locations incl. Phoenix
Sponsor: 858 Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT06395519·Phase 1, Phase 2·Recruiting·Listed May 2024